Healthcare spending is eating up an increasingly large portion of the federal budget, to the point that over the next 30 years, per the nonpartisan Congressional Budget Office, healthcare outlays will consume $1 out of every $10 of our annual total economic output.
Thankfully, private-sector scientific innovation may help tamp down the healthcare red ink, specifically semaglutide, better known as Ozempic. Approved in 2017 by the Food and Drug Administration for use in adults with Type 2 diabetes, Ozempic has taken the world by storm for its unparalleled success as an anti-obesity measure. Even television viewers unfamiliar with the drug have likely heard its commercial jingle, “Oh, Oh, Oh, Ozempic,” a riff on David Paton’s 1974 song “Magic,” which reached No. 5 in the United States on the Billboard Hot 100.